Kicman A - Search Results

1

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy.

Guszczyn T, Kulesza M, Kicman A, Motyka J, Ławicki S. Guszczyn T, et al. Among authors: kicman a. Med Sci Monit. 2023 Dec 18;29:e941523. doi: 10.12659/MSM.941523. Med Sci Monit. 2023. PMID: 38105547 Free PMC article.

2

Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer.

Motyka J, Gacuta E, Kicman A, Kulesza M, Ławicki P, Ławicki S. Motyka J, et al. Among authors: kicman a. J Clin Med. 2022 Nov 12;11(22):6694. doi: 10.3390/jcm11226694. J Clin Med. 2022. PMID: 36431173 Free PMC article.

3

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients.

Kicman A, Niczyporuk M, Kulesza M, Motyka J, Ławicki S. Kicman A, et al. Cancer Manag Res. 2022 Nov 30;14:3359-3382. doi: 10.2147/CMAR.S385658. eCollection 2022. Cancer Manag Res. 2022. PMID: 36474934 Free PMC article. Review.

4

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients.

Ławicki P, Malinowski P, Motyka J, Ławicki M, Kicman A, Kulesza M, Gacuta E, Guszczyn T, Januszkiewicz M, Zbucka-Krętowska M, Ławicki S. Ławicki P, et al. Among authors: kicman a. J Clin Med. 2023 Mar 30;12(7):2618. doi: 10.3390/jcm12072618. J Clin Med. 2023. PMID: 37048701 Free PMC article.

5

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients.

Motyka J, Kicman A, Kulesza M, Ławicki S. Motyka J, et al. Among authors: kicman a. Cancers (Basel). 2023 Jun 8;15(12):3118. doi: 10.3390/cancers15123118. Cancers (Basel). 2023. PMID: 37370728 Free PMC article. Review.

6

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer.

Motyka J, Gacuta E, Kicman A, Kulesza M, Malinowski P, Ławicki S. Motyka J, et al. Among authors: kicman a. Cancer Manag Res. 2023 Jul 4;15:573-589. doi: 10.2147/CMAR.S416382. eCollection 2023. Cancer Manag Res. 2023. PMID: 37426394 Free PMC article.

7

Importance of Metalloproteinase 8 (MMP-8) in the Diagnosis of Periodontitis.

Zalewska EA, Ławicka R, Grygorczuk P, Nowosielska M, Kicman A, Ławicki S. Zalewska EA, et al. Among authors: kicman a. Int J Mol Sci. 2024 Feb 27;25(5):2721. doi: 10.3390/ijms25052721. Int J Mol Sci. 2024. PMID: 38473967 Free PMC article. Review.

8

Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer.

Kicman A, Gacuta E, Kulesza M, Będkowska EG, Marecki R, Klank-Sokołowska E, Knapp P, Niczyporuk M, Ławicki S. Kicman A, et al. Int J Mol Sci. 2024 Jun 6;25(11):6265. doi: 10.3390/ijms25116265. Int J Mol Sci. 2024. PMID: 38892452 Free PMC article.

9

The Effectiveness of Treating Osgood-Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease.

Guszczyn T, Kulesza M, Maciąg G, Kicman A, Ławicki S. Guszczyn T, et al. Among authors: kicman a. J Clin Med. 2024 Jul 19;13(14):4220. doi: 10.3390/jcm13144220. J Clin Med. 2024. PMID: 39064260 Free PMC article.

10

Title Changes in Plasma Levels of Selected Matrix Metalloproteinases (MMPs) Enzymes in Patients with Osgood-Schlatter Disease (OSD).

Kulesza M, Guszczyn T, Kicman A, Ławicki S. Kulesza M, et al. Among authors: kicman a. J Clin Med. 2024 Sep 24;13(19):5655. doi: 10.3390/jcm13195655. J Clin Med. 2024. PMID: 39407715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters